by Jessica Casebolt | Feb 17, 2023 | Payers, Tea Leaves
Medicare Advantage and Medicare drug plans told the Centers for Medicaid and Medicare Services (CMS) that too much regulation at once could drive up costs and result in increased premiums or fewer benefits. Public comment closed this week on a proposal to crack...
by Jessica Casebolt | Feb 16, 2023 | Payers, Tea Leaves
The advocacy group Better Medicare Alliance (BMA) launched a new effort Wednesday to persuade the Biden administration to overhaul a proposal it says will cut Medicare Advantage (MA) plan payments by 2.27 percent. BMA, which lobbies Congress and the federal government...
by Jessica Casebolt | Feb 15, 2023 | Payers, Tea Leaves
The Biden administration rolled out three new payment models intended to lower drug costs, including new Medicare coverage options for drugs cleared under accelerated approval. The Center for Medicare and Medicaid Innovation (CMMI) did not give a timeline for when the...
by Jordana Choucair | Feb 13, 2023 | Payers
An analysis conducted by the Health Care Cost Institute found that employer-sponsored health plans pay significantly more than Medicare for costly physician-administered drugs. Researchers found that between 2016 and 2020 price markups increased for five of the top 10...
by Jordana Choucair | Feb 13, 2023 | Payers
CMS notified providers and health plans involved in dispute resolution under the Surprise Billing Act to put their payment determinations on hold. Last week, a federal judge ruled in favor of the Texas Medical Association regarding a challenge against the Biden...
by Jordana Choucair | Feb 9, 2023 | Payers
A new survey from Willis Towers Watson revealed that employers are examining their relation with health and wellbeing vendors to ensure they are getting their money’s worth and receiving the services that the vendor said they would deliver. The survey found that 88...
Recent Comments